Jan. 10, 2014—Vanderbilt researchers have discovered that variation in the gene encoding the potassium channel GIRK1 plays a role in modulating human pain perception.
Dec. 13, 2013—The protein CK1 delays cell division to avoid the generation of defects that drive tumorigenesis.
Nov. 25, 2013—A study of mitochondrial DNA mutations suggests they result from a process that selects for particular mutations in certain tissues.
Nov. 22, 2013—Using computational tools to search for the genetic basis of what makes us human, Vanderbilt Assistant Professor of Biomedical Informatics Tony Capra and colleagues at the University of California-San Francisco have identified promising candidate regions.
Nov. 21, 2013—Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.
Oct. 25, 2013—Vanderbilt researchers have identified a key regulator of cell division.
Oct. 24, 2013—Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.
Sep. 18, 2013—Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
Sep. 16, 2013—New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
Aug. 26, 2013—A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
Aug. 14, 2013—A biomarker for oxidative stress is elevated in patients with both autism spectrum disorder and gastrointestinal dysfunction, suggesting opportunities for individualized approaches to clinical care.
Jul. 29, 2013—A motor protein that helps drive cell division may be a promising new target for cancer therapeutics.